BACKGROUND: Chronic immune activation is a hallmark of HIV infection and has been postulated as major factor in the pathogenesis of AIDS. Recent evidence suggests that activation of immune cells is triggered by microbial translocation through the impaired gastrointestinal barrier. METHODS: To determine the association between microbial translocation and disease progression, we have retrospectively analyzed microbial products, viral load and markers of immune activation in a cohort of 37 simian immunodeficiency virus-infected rhesus monkeys, divided in two groups with distinct disease courses. RESULTS: As seen in HIV-infected patients, we found elevated levels of lipopolysaccharide (LPS) in infected animals. However, LPS levels or LPS control mechanisms like endotoxin core antibodies or LPS-binding protein did not differ between groups with different disease progression. In contrast, neopterin, a metabolic product of activated macrophages, was higher in fast progressors than in slow progressors. CONCLUSION: Our data indicate that translocation of microbial products is not the major driving force of immune activation in HIV infection.
BACKGROUND: Chronic immune activation is a hallmark of HIV infection and has been postulated as major factor in the pathogenesis of AIDS. Recent evidence suggests that activation of immune cells is triggered by microbial translocation through the impaired gastrointestinal barrier. METHODS: To determine the association between microbial translocation and disease progression, we have retrospectively analyzed microbial products, viral load and markers of immune activation in a cohort of 37 simian immunodeficiency virus-infected rhesus monkeys, divided in two groups with distinct disease courses. RESULTS: As seen in HIV-infectedpatients, we found elevated levels of lipopolysaccharide (LPS) in infected animals. However, LPS levels or LPS control mechanisms like endotoxin core antibodies or LPS-binding protein did not differ between groups with different disease progression. In contrast, neopterin, a metabolic product of activated macrophages, was higher in fast progressors than in slow progressors. CONCLUSION: Our data indicate that translocation of microbial products is not the major driving force of immune activation in HIV infection.
Authors: A T Hutchison; J E Schmitz; C J Miller; K J Sastry; P N Nehete; A M Major; A A Ansari; N Tatevian; D E Lewis Journal: J Med Primatol Date: 2011-07-07 Impact factor: 0.667
Authors: Thorsten Demberg; Amelia C Ettinger; Stanley Aladi; Katherine McKinnon; Thea Kuddo; David Venzon; L Jean Patterson; Terry M Phillips; Marjorie Robert-Guroff Journal: Vaccine Date: 2011-06-25 Impact factor: 3.641
Authors: Emmanouil Papasavvas; Livio Azzoni; Andrea Foulkes; Avy Violari; Mark F Cotton; Maxwell Pistilli; Griffin Reynolds; Xiangfan Yin; Deborah K Glencross; Wendy S Stevens; James A McIntyre; Luis J Montaner Journal: Pediatr Infect Dis J Date: 2011-10 Impact factor: 2.129
Authors: Pietro Presicce; Julia M Shaw; Christopher J Miller; Barbara L Shacklett; Claire A Chougnet Journal: AIDS Date: 2012-01-28 Impact factor: 4.177
Authors: Lauren A Canary; Carol L Vinton; David R Morcock; Jordan B Pierce; Jacob D Estes; Jason M Brenchley; Nichole R Klatt Journal: J Immunol Date: 2013-02-11 Impact factor: 5.422
Authors: Michael A Eller; Kim G Blom; Veronica D Gonzalez; Leigh Anne Eller; Prossy Naluyima; Oliver Laeyendecker; Thomas C Quinn; Noah Kiwanuka; David Serwadda; Nelson K Sewankambo; Boonrat Tasseneetrithep; Maria J Wawer; Ronald H Gray; Mary A Marovich; Nelson L Michael; Mark S de Souza; Fred Wabwire-Mangen; Merlin L Robb; Jeffrey R Currier; Johan K Sandberg Journal: PLoS One Date: 2011-04-19 Impact factor: 3.240